Chinese Public Firms Implicated In Ambroxol Injection Quality Storm
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA noted it received 2,973 ADR reports on ambroxol hydrochloride injections in 2011, which included 169 severe cases, 79 of which were pediatric ADRs.